Identification of a new Arylsulfatase A (ARSA) gene mutation in Tunisian patients with metachromatic leukodystrophy (MLD)

J Neurol Sci. 2009 Dec 15;287(1-2):278-80. doi: 10.1016/j.jns.2009.07.023. Epub 2009 Aug 21.

Abstract

Metachromatic leukodystrophy (MLD) is an autosomal recessive, lysosomal storage disease caused by a deficiency of the enzyme arylsulfatase A (ARSA). The aim of the present study was to identify the molecular basis of MLD in Tunisian population. Two Tunisian patients with late infantile MLD were studied. Both patients were homozygous for a new missense mutation that causes a substitution of Trp in Gly p.W124G. This is the first mutation of ARSA gene described in Tunisian population.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Central Nervous System / enzymology
  • Central Nervous System / pathology
  • Central Nervous System / physiopathology
  • Cerebroside-Sulfatase / deficiency
  • Cerebroside-Sulfatase / genetics*
  • Cerebrosides / metabolism
  • Child, Preschool
  • DNA Mutational Analysis
  • Genetic Markers / genetics
  • Genetic Predisposition to Disease / ethnology
  • Genetic Predisposition to Disease / genetics*
  • Genetic Testing
  • Genotype
  • Humans
  • Leukodystrophy, Metachromatic / enzymology*
  • Leukodystrophy, Metachromatic / ethnology
  • Leukodystrophy, Metachromatic / genetics*
  • Male
  • Mutation / genetics*
  • Tunisia / ethnology

Substances

  • Cerebrosides
  • Genetic Markers
  • cerebroside sulfate
  • Cerebroside-Sulfatase